stockportfolio.pro
Stocks / TECH vs TEM
TECH vs TEM
Bio-Techne Corporation and Tempus AI, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Bio-Techne Corporation (TECH) | Tempus AI, Inc. (TEM) | |
|---|---|---|
| Market cap | $8.5B | $8.7B |
| Revenue (latest FY) | $1.22B | $1.27B |
| Net income (latest FY) | $73.40M | $-245.03M |
| Revenue growth (5y CAGR) | 10.5% | 58.3% |
| Net margin | 6.0% | -19.3% |
| Return on equity | 3.8% | -49.9% |
| P/E ratio | 77.7 | — |
| Dividend yield | 0.6% | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open TECH — free Open TEM — freeFrequently asked questions
Which is bigger, TECH or TEM?
Tempus AI, Inc. is larger by market capitalization — $8.7B versus $8.5B.
Which grows faster, TECH or TEM?
Over the last five fiscal years, Tempus AI, Inc. grew revenue faster — 58.3%/yr versus 10.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.